The Exchange had sought clarification from Abbott India with respect to news appearing in Hindustan Times on October 15, 2015 titled ‘DCGI orders Abbott to test Phensedyl syrup.’ Abbott India response is enclosed.
The above information is a part of company’s filings submitted to BSE.